TI
IMUX icon

Trexquant Investment’s Immunic IMUX Stock Holding History

Trexquant Investment’s Portfolio IMUX Stock Details IMUX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-1,067
Closed -$131K – 1306
2021
Q2 		$131K Buy
+1,067
New +$148K 0.01% 988
2021
Q1 		– Sell
-1,767
Closed -$270K – 1272
2020
Q4 		$270K Buy
1,767
+763
+76% +$137K 0.03% 750
2020
Q3 		$186K Buy
+1,004
New +$164K 0.01% 1094

Other funds holding IMUX

OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $977M AUM 110.37% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Trexquant Investment's IMUX Position: Q3 2021 in Review

Trexquant Investment sold out of Immunic (IMUX) in Q3 2021, closing a stake of 1,067 shares — an estimated $131K sold.

Trexquant Investment first reported a position in IMUX in Q3 2020 and held it in 3 quarters. The position peaked at $270K in Q4 2020. 68 funds tracked by Wall St. Rank hold IMUX as of Q3 2021.

  • Trexquant Investment reported no remaining Immunic position as of Q3 2021 after selling out during the quarter.
  • Trexquant Investment sold 1,067 Immunic shares in Q3 2021, an estimated $131K.
  • Trexquant Investment first reported a position in Immunic in Q3 2020 and held it in 3 quarters.
  • Trexquant Investment's Immunic position peaked at $270K in Q4 2020.
  • 68 funds tracked by Wall St. Rank held Immunic as of Q3 2021.

Based on Trexquant Investment's 13F filing for Q3 2021, filed 12 Nov 2021.